Sotera Health Company (SHC) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $15.93. It has a SharesGrow Score of 64/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of SHC = $22.50 (+41.2% from the current price, the stock appears undervalued). Analyst consensus target is SHC = $23 (+42.3% upside).
Valuation: SHC trades at a trailing Price-to-Earnings (P/E) of 54.9 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 6.35.
Financials: revenue is $1.2B, +5.1%/yr average growth. Net income is $78M, growing at +61.3%/yr. Net profit margin is 6.7% (thin). Gross margin is 55.5% (+0 pp trend).
Balance sheet: total debt is $2.3B against $606M equity (Debt-to-Equity (D/E) ratio 3.75, leveraged). Current ratio is 2.46 (strong liquidity). Debt-to-assets is 69.7%. Total assets: $3.3B.
Analyst outlook: 11 / 12 analysts rate SHC as buy (92%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 42/100 (Partial), Growth 83/100 (Pass), Past 75/100 (Partial), Health 33/100 (Fail), Moat 70/100 (Pass), Future 100/100 (Pass), Income 45/100 (Partial).
